Cisplatin protects mice from challenge of Cryptococcus neoformans by targeting the Prp8 intein
Journal Article
·
· Emerging Microbes & Infections
- New York State Department of Health, Wadsworth Center, Albany, NY, USA
- College of Pharmaceutical Sciences, Southwest University, Chongqing, People’s Republic of China
- Department of Biological Sciences and RNA Institute, University at Albany, Albany, NY, USA
- New York State Department of Health, Wadsworth Center, Albany, NY, USA, Department of Biomedical Sciences, School of Public Health, University at Albany, Albany, NY, USA
- Department of Biological Sciences and RNA Institute, University at Albany, Albany, NY, USA, Department of Biomedical Sciences, School of Public Health, University at Albany, Albany, NY, USA
Not Available
- Sponsoring Organization:
- USDOE Office of Science (SC), Biological and Environmental Research (BER)
- OSTI ID:
- 1529025
- Journal Information:
- Emerging Microbes & Infections, Journal Name: Emerging Microbes & Infections Journal Issue: 1 Vol. 8; ISSN 2222-1751
- Publisher:
- Informa UK LimitedCopyright Statement
- Country of Publication:
- United Kingdom
- Language:
- English
Similar Records
Natural cellular resistance of beige mice against Cryptococcus neoformans
The Structure of Cryptococcus Neoformans Thymidylate Synthase Suggests Strategies for Using Target Dynamics for Species-Specific Inhibition
Structures of Cryptococcus neoformans Protein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal Pathogens
Journal Article
·
1986
· J. Immunol.; (United States)
·
OSTI ID:6830070
The Structure of Cryptococcus Neoformans Thymidylate Synthase Suggests Strategies for Using Target Dynamics for Species-Specific Inhibition
Journal Article
·
2006
· Acta Crystallogr.D Biol.Crystallogr.61:1320,2005
·
OSTI ID:892583
+4 more
Structures of Cryptococcus neoformans Protein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal Pathogens
Journal Article
·
2012
· J. Biol. Chem.
·
OSTI ID:1041325
+4 more